How to appeal a Blue Cross Blue Shield of Massachusetts hospice / palliative — eligibility, gip, recertification, concurrent care denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross Blue Shield of Massachusetts-specific note: Non-profit; ~3M members. MA has the most expansive state mandated benefits in the US and strong supplemental parity rules. MA OPP (Office of Patient Protection) provides external review separately from carriers — distinct from federal IRO process for fully-insured plans.

What Blue Cross Blue Shield of Massachusetts's policy requires for hospice / palliative — eligibility, gip, recertification, concurrent care

Cited policy: Anthem / BCBS Concurrent Care for Children — Medicaid managed care plans must cover per ACA §2302 (42 USC §1396d(o)(1)); commercial plans increasingly follow voluntarily

Child under 21 enrolled in Medicaid or CHIP may receive disease-directed (curative) treatment AND hospice services concurrently; documentation of both regimens; election of hospice benefit by parent/guardian.

How Blue Cross Blue Shield of Massachusetts denies hospice / palliative — eligibility, gip, recertification, concurrent care — and how to counter it

Where Blue Cross Blue Shield of Massachusetts pushes back: 1) 'Curative care excludes hospice election'; 2) 'Hospice + curative considered duplicative'; 3) 'ACA §2302 not applicable to this plan'; 4) 'Concurrent care provider not in-network'.

Counter-arguments that hold up: Cite ACA §2302 (Affordable Care Act Section 2302), codified at 42 USC §1396d(o)(1). Cite CMS Informational Bulletin (CIB) on Concurrent Care for Children Requirement (Sept 2010 + subsequent updates). Cite NHPCO Pediatric Hospice and Palliative Care Standards. Document patient age <21, Medicaid/CHIP enrollment, curative regimen (oncologic protocol, transplant, etc.), and hospice election. For commercial plans cite voluntary alignment with concurrent-care policy and AAP Section on Hospice and Palliative Medicine position.

What Blue Cross Blue Shield of Massachusetts typically denies for hospice / palliative — eligibility, gip, recertification, concurrent care

Across Blue Cross Blue Shield of Massachusetts's commercial and Medicare books, denials cluster around a small number of patterns. For hospice / palliative — eligibility, gip, recertification, concurrent care, expect:

• MA-specific mandated benefit disputes (most generous in US)
• Behavioral health parity (MA has tighter parity rules than federal MHPAEA)
• Tiered-network provider disputes
• Specialty drug PA

Treatments most often denied in this category

These are the hospice / palliative — eligibility, gip, recertification, concurrent care treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Hospice eligibility
• Hospice recertification
• Hospice GIP
• Hospice CHC
• Hospice respite
• Hospice routine

How to submit the appeal to Blue Cross Blue Shield of Massachusetts

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross Blue Shield of Massachusetts cited in the denial.
3. File the appeal through Blue Cross Blue Shield of Massachusetts's portal (members: https://home.bluecrossma.com ; providers: https://provider.bluecrossma.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross Blue Shield of Massachusetts's prior-authorization criteria by drug: Blue Cross Blue Shield of Massachusetts PA criteria on ApprovalHelp.